GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve (IST:ANGEN) » Definitions » EBIT per Share

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) EBIT per Share : ₺0.66 (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT per Share?

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT per Share for the three months ended in Sep. 2023 was ₺0.07. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was ₺0.66.

During the past 12 months, the average EBIT per Share Growth Rate of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve was -116.20% per year. During the past 3 years, the average EBIT per Share Growth Rate was 149.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT per Share or its related term are showing as below:

IST:ANGEN' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 149.3   Med: 359.6   Max: 569.9
Current: 149.3

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve was 569.90% per year. The lowest was 149.30% per year. And the median was 359.60% per year.

IST:ANGEN's 3-Year EBIT Growth Rate is ranked better than
99.45% of 725 companies
in the Medical Devices & Instruments industry
Industry Median: 5.7 vs IST:ANGEN: 149.30

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT for the three months ended in Sep. 2023 was ₺15.6 Mil.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT per Share Historical Data

The historical data trend for Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT per Share Chart

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
EBIT per Share
0.01 0.04 1.65 3.07 1.55

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Quarterly Data
Dec18 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.10 0.06 0.42 0.07

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

EBIT per Share(A: Dec. 2022 )
=EBIT/Shares Outstanding (Diluted Average)
=341.715/220.000
=1.55

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

EBIT per Share(Q: Sep. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=15.565/220.000
=0.07

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve  (IST:ANGEN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve EBIT per Share Related Terms

Thank you for viewing the detailed overview of Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Business Description

Traded in Other Exchanges
N/A
Address
Egitim Mah. Kasap Ismail, Sk. No:10 D:23, Kadikoy, Istanbul, TUR, 34722
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve Ticaret AS is an international biotechnology company. It is engaged in designing, developing, and manufacturing Real-Time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments. It also manufactures NA Extraction kits, Microbiology kits, Genetic Disorders kits, Panel kits, Sequencing kits, Food Testing kits.

Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Headlines

No Headlines